Literature DB >> 6965679

Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

G V Doern, S A Morse.   

Abstract

Eleven clinically significant isolates of Branhamella catarrhalis grew well on modified Thayer-Martin medium and produced beta-lactamase, but did not grow on nutrient agar at 22 degrees C. Minimum inhibitory concentrations of vancomycin, colistin, and trimethoprim were found to be higher than the concentrations of these antibiotics in modified Thayer-Martin medium. The criteria necessary for laboratory identification of B. catarrhalis are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965679      PMCID: PMC273353          DOI: 10.1128/jcm.11.2.193-195.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Improved medium selective for cultivation of N. gonorrhoeae and N. meningitidis.

Authors:  J D Thayer; J E Martin
Journal:  Public Health Rep       Date:  1966-06       Impact factor: 2.792

2.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

3.  Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.

Authors:  D J McNeely; C S Kitchens; R M Kluge
Journal:  Am Rev Respir Dis       Date:  1976-08

4.  Branhamella (Neisseria) catarrhalis as pathogen.

Authors:  G Ninane; J Joly; P Piot; M Kraytman
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

5.  In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.

Authors:  B E Malmvall; J E Brorsson; J Johnsson
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

6.  Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

Authors:  A Percival; J E Corkill; J Rowlands; R B Sykes
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

7.  Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.

Authors:  G Ninane; J Joly; M Kraytman; P Piot
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

8.  Some properties of the beta-lactamase genes in Staphylococcus epidermidis.

Authors:  J N Baldwin; R H Strickland; M F Cox
Journal:  Appl Microbiol       Date:  1969-10
  8 in total
  35 in total

1.  Labile type-specific antigen of Moraxella catarrhalis.

Authors:  S J Norkus; J W Vennes
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

2.  Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults.

Authors:  T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

3.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

Authors:  C DiGiovanni; T V Riley; G F Hoyne; R Yeo; P Cooksey
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

4.  Characterisation of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory.

Authors:  F Ahmad; H Young; D T McLeod; M J Croughan; M A Calder
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

5.  Fluorescent-antibody-negative penicillinase-producing Neisseria gonorrhoeae.

Authors:  D T Walton
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Branhamella catarrhalis in lower respiratory tract secretions in adults.

Authors:  H Schønheyder; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

7.  Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.

Authors:  I Luman; R W Wilson; R J Wallace; D R Nash
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 8.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  Clinical evaluation of the Vitek Neisseria-Haemophilus Identification card.

Authors:  W M Janda; P J Malloy; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

10.  Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.

Authors:  J M Aitken; P E Thornley
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.